Impact of COVID-19 on patient and healthcare professional attitudes, beliefs, and behaviors toward the healthcare system and on the dynamics of the healthcare pathway

Table 1 Screening Criteria for Patients and HCPs

Patients	HCPs^a
VMS • Age 50–59 years • Experience ≥5 hot flashes/day lasting 10 min • ≥12 months since menstrual period • Willing to see a doctor and take medical treatment	Oncologists^b • Minimum of 15 prostate cancer and mUC patients • Must prescribe infusion therapy
Overactive bladder • Willing to see a doctor and try drug treatment • Mix of early-, mid-, and late-stage	Gynecologists • Minimum 15 VMS patients
Prostate cancer • Age 61–68 years • Must be receiving treatment	Urologists^b,c • Minimum 10 prostate cancer and 5 mUC patients • Must prescribe infusion therapy
mUC • Age 51–65 years • Must be receiving treatment • Metastatic (US) and nonmetastatic (Japan) cancer	Primary care physicians • Minimum 15 OAB patients

Abbreviations: HCP Healthcare professional, mUC Metastatic urothelial carcinoma, OAB Overactive bladder, US United States, VMS Vasomotor symptoms
^aHCPs were required to have been in medical practice for at least 2 but no more than 35 years; US HCPs were recruited from states where there were sufficient cases of COVID-19 to impact their practice
^bUrologists and oncologists were required to treat both prostate cancer and mUC
^cUrologists were required to have prescribed infusion therapy; US urologists must not work at a government hospital and Japanese urologists must work at an academic hospital or private practice

ISSN: 1472-6963